These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1158 related items for PubMed ID: 30358920

  • 1. Audiological and clinical outcomes of a transcutaneous bone conduction hearing implant: Six-month results from a multicentre study.
    den Besten CA, Monksfield P, Bosman A, Skarzynski PH, Green K, Runge C, Wigren S, Blechert JI, Flynn MC, Mylanus EAM, Hol MKS.
    Clin Otolaryngol; 2019 Mar; 44(2):144-157. PubMed ID: 30358920
    [Abstract] [Full Text] [Related]

  • 2. Clinical performance of a new magnetic bone conduction hearing implant system: results from a prospective, multicenter, clinical investigation.
    Briggs R, Van Hasselt A, Luntz M, Goycoolea M, Wigren S, Weber P, Smeds H, Flynn M, Cowan R.
    Otol Neurotol; 2015 Jun; 36(5):834-41. PubMed ID: 25634465
    [Abstract] [Full Text] [Related]

  • 3. A multicenter study on objective and subjective benefits with a transcutaneous bone-anchored hearing aid device: first Nordic results.
    Hougaard DD, Boldsen SK, Jensen AM, Hansen S, Thomassen PC.
    Eur Arch Otorhinolaryngol; 2017 Aug; 274(8):3011-3019. PubMed ID: 28534117
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A New Active Osseointegrated Implant System in Patients with Single-Sided Deafness.
    Willenborg K, Avallone E, Maier H, Lenarz T, Busch S.
    Audiol Neurootol; 2022 Aug; 27(1):83-92. PubMed ID: 33902037
    [Abstract] [Full Text] [Related]

  • 6. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment.
    Ontario Health (Quality) .
    Ont Health Technol Assess Ser; 2020 Aug; 20(1):1-165. PubMed ID: 32194878
    [Abstract] [Full Text] [Related]

  • 7. Hearing Outcomes with Percutaneous and Transcutaneous BAHA® Technology in Conductive and Mixed Hearing Loss.
    Tobia A, Yehudai N, Khnifes R, Shpak T, Roth O, Khayr R, Luntz M.
    Otol Neurotol; 2021 Oct 01; 42(9):1382-1389. PubMed ID: 34528924
    [Abstract] [Full Text] [Related]

  • 8. Hearing Benefit and Rated Satisfaction in Children with Unilateral Conductive Hearing Loss Using a Transcutaneous Magnetic-Coupled Bone-Conduction Hearing Aid.
    Polonenko MJ, Carinci L, Gordon KA, Papsin BC, Cushing SL.
    J Am Acad Audiol; 2016 Oct 01; 27(10):790-804. PubMed ID: 27885975
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a new powerful bone-anchored hearing system: a comparison study.
    Bosman AJ, Snik AF, Hol MK, Mylanus EA.
    J Am Acad Audiol; 2013 Jun 01; 24(6):505-13. PubMed ID: 23886427
    [Abstract] [Full Text] [Related]

  • 10. The bone conduction implant: Clinical results of the first six patients.
    Reinfeldt S, Håkansson B, Taghavi H, Fredén Jansson KJ, Eeg-Olofsson M.
    Int J Audiol; 2015 Jun 01; 54(6):408-16. PubMed ID: 25705995
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Audiological Results Between a Transcutaneous and a Percutaneous Bone Conduction Instrument in Conductive Hearing Loss.
    Gerdes T, Salcher RB, Schwab B, Lenarz T, Maier H.
    Otol Neurotol; 2016 Jul 01; 37(6):685-91. PubMed ID: 27093021
    [Abstract] [Full Text] [Related]

  • 12. Comparisons of sound processors based on osseointegrated implants in patients with conductive or mixed hearing loss.
    Pfiffner F, Caversaccio MD, Kompis M.
    Otol Neurotol; 2011 Jul 01; 32(5):728-35. PubMed ID: 21646934
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multicenter Clinical Investigation of a New Active Osseointegrated Steady-State Implant System.
    Mylanus EAM, Hua H, Wigren S, Arndt S, Skarzynski PH, Telian SA, Briggs RJS.
    Otol Neurotol; 2020 Oct 01; 41(9):1249-1257. PubMed ID: 32925852
    [Abstract] [Full Text] [Related]

  • 15. Results of a 2-Year Prospective Multicenter Study Evaluating Long-term Audiological and Clinical Outcomes of a Transcutaneous Implant for Bone Conduction Hearing.
    Kruyt IJ, Monksfield P, Skarzynski PH, Green K, Runge C, Bosman A, Blechert JI, Wigren S, Mylanus EAM, Hol MKS.
    Otol Neurotol; 2020 Aug 01; 41(7):901-911. PubMed ID: 32310837
    [Abstract] [Full Text] [Related]

  • 16. Outcomes after Application of Active Bone Conducting Implants.
    Koro E, Werner M.
    Audiol Neurootol; 2019 Aug 01; 24(4):197-205. PubMed ID: 31499490
    [Abstract] [Full Text] [Related]

  • 17. The evaluation of a surgery and the short-term benefits of a new active bone conduction hearing implant - the Osia®.
    Gawęcki W, Gibasiewicz R, Marszał J, Błaszczyk M, Gawłowska M, Wierzbicka M.
    Braz J Otorhinolaryngol; 2022 Aug 01; 88(3):289-295. PubMed ID: 32713797
    [Abstract] [Full Text] [Related]

  • 18. The effect of percutaneous and transcutaneous BAHA on hearing and subjective auditory abilities: A comparative study.
    Mungan Durankaya S, Olgun Y, Kiremitçi I, Evin Eskicioğlu H, Güneri EA, Kirazli G, Gürkan S, Erdağ TK, Kirkim G.
    Medicine (Baltimore); 2024 Sep 20; 103(38):e39697. PubMed ID: 39312344
    [Abstract] [Full Text] [Related]

  • 19. Clinical performance, safety, and patient-reported outcomes of an active osseointegrated bone-conduction hearing implant system at 24-month follow-up.
    Cowan R, Lewis AT, Hallberg C, Tong MCF, Birman CS, Ng IH, Briggs R.
    Eur Arch Otorhinolaryngol; 2024 Feb 20; 281(2):683-691. PubMed ID: 37552281
    [Abstract] [Full Text] [Related]

  • 20. Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant.
    Sprinzl G, Toner J, Koitschev A, Berger N, Keintzel T, Rasse T, Baumgartner WD, Honeder C, Magele A, Plontke S, Götze G, Schmutzhard J, Zelger P, Corkill S, Lenarz T, Salcher R.
    Eur Arch Otorhinolaryngol; 2023 Apr 20; 280(4):1565-1579. PubMed ID: 36625869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.